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A sample preparation method that combines a modified target plate with a nanoscale reversed-
phase column (nanocolumn) was developed for detection of neuropeptides by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). A gold-coated MALDI plate
was modified with an octadecanethiol (ODT) self-assembled monolayer to create a hydrophobic surface
that could concentrate peptide samples into a ∼200–500-µm diameter spot. The spot sizes generated were
comparable to those obtained for a substrate patterned with 200-µm hydrophilic spots on a hydrophobic
substrate. The sample spots on the ODT-coated plate were 100-fold smaller than those formed on an
unmodified gold plate with a 1-µl sample and generated 10 to 50 times higher mass sensitivity for
peptide standards by MALDI-TOF MS. When the sample was deposited on an ODT-modified plate from a
nanocolumn, the detection limit for peptides was as low as 20 pM for 5-µl samples corresponding to 80 amol
deposited. This technique was used to analyze extracts of microwave-fixed tissue from rat brain striatum.
Ninety-eight putative peptides were detected including several that had masses matching neuropeptides
expected in this brain region such as substance P, rimorphin, and neurotensin. Twenty-three peptides
had masses that matched peaks detected by capillary liquid chromatography with electrospray ionization
MS.1,2 Copyright  2005 John Wiley & Sons, Ltd.
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INTRODUCTION
Neuropeptides constitute an important family of bioactive
compounds that are involved in many physiological func-
tions including learning, metabolism, appetite regulation,
mood, and sensory perception.3,4 Expression and processing
of neuropeptides may change with physiological condition;
therefore, detection of such compounds in tissue samples
is of interest for neuroscience applications. Neuropeptides
tend to be present at low concentrations, creating a significant
analytical challenge for detection and identification. The dif-
ficulty in detecting small amounts of peptide is aggravated
by in vivo processing of peptides, which results in many
related peptides being colocalized in tissues.
Matrix-assisted laser desorption/ionization mass spec-
trometry (MALDI-MS) has become an important tool for the
analysis of neuropeptides because of its high sensitivity and
mass accuracy.5 – 9 The quality of MALDI-MS data, including
sensitivity and reproducibility, is critically dependent upon
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sample preparation and deposition. The most commonly
used sample preparation method, the dried-droplet,10 can
usually only achieve detection limits in the low femtomole
range for peptides. The relatively poor sensitivity is par-
tially due to the large mismatch between sample spot size
(1–4 mm) and laser irradiation spot size (50–200 µm), result-
ing in only a small fraction of the sample being exposed to
the laser for ion generation. This method also suffers from
poor shot-to-shot and sample-to-sample reproducibility due
to the heterogeneity of sample crystallization.
Recent work has demonstrated several methods for
improving mass sensitivity for MALDI-MS by miniaturizing
the sample spot size.11 – 17 One approach has been the confine-
ment of samples to small areas using modified target plates
such as picoliter silicon vials,11 hydrophilic sample wells
in a hydrophobic coating,12 patterned monolayer/polymer
films,13 and hydrophobic surfaces.14 In these methods, sam-
ples ranging from 250 pl to 1.5 µl are deposited on the target.
As solvent evaporates, the sample is confined to a small sur-
face, typically 100–400 µm in diameter. Such confinement has
led to a limit of detection (LOD) of 2.5 to 100 amol and concen-
tration LOD range from sub-nanomolars to 10 nM. Samples
Copyright  2005 John Wiley & Sons, Ltd.
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may also be confined by using specialized sample deposition
methods such as a piezoelectric flow-through microdispenser
that deposits 60-pl spots,15 electrospray sample deposition,16
and a three-layer sample preparation protocol in combina-
tion with microspot sample deposition.17 These methods can
achieve attomole or better LODs; however, they are of limited
utility for practical analysis of complex tissue samples if the
sample is not concentrated and desalted prior to deposition.
An approach to microscale sample deposition that
incorporates sample purification has been to utilize a 30–50-
nl bed of reversed-phase chromatography particles packed
into a pipette tip as a solid-phase extraction cartridge.5,18 – 20
This so-called ‘nanocolumn’ method allows samples to
be preconcentrated, desalted, and eluted in low volumes
(50–100 nl) as small spots. Using solutions with a few
hundred picomolar concentration of peptide, this method
has been reported to yield mass LODs of low attomole
for peptide standards, which is a considerable improvement
over more commonly used solid-phase extraction methods.21
The nanocolumn has been used to analyze tryptic digests
of protein and immunoprecipitation-purified neuropeptides
with LODs in the low femtomole range.5,20
In this work, we test the hypothesis that combining
the nanocolumn technique with modified surfaces that
confine samples to small spots would improve the detection
limit over either approach alone. The sample confinement
method used is to coat the MALDI target plate with a
hydrophobic monolayer of 1-octadecanethiol (1-ODT). The
results demonstrate significant improvement in sensitivity
with a 20 pM concentration LOD for 5-µl samples. As a result
of the improved LODs, we were able to successfully utilize
the method to detect neuropeptides extracted from rat brain




All solvents and chemicals used were of analytical grade. All
organic solvents and water were from Burdick & Jackson
(Muskegon, MI, USA). ˛-cyano-4-hydroxycinnamic acid
(CHCA), 5-dihydrobenzoic acid (DHB), peptide standards,
ODT, trifluroacetic acid (TFA), and sodium dodecylsulfate
(SDS) were purchased from Sigma (St Louis, MO, USA).
Potassium chloride was obtained from ICN Biomedicals Inc
(Irvine, CA, USA). Photoresist (AZ 9260) and developer
(AZ 400) were from Clariant Corp. (Summerville, NJ, USA).
Poly(dimethylsiloxane) (PDMS) (RTV 615A and RTV 615B)
was obtained from GE silicones (Waterford, NY, USA).
GELoader tips were purchased from Brinkmann Instruments
(Westbury, NY, USA). POROS 20 R2 was purchased from
Applied Biosystems (Foster City, CA, USA). The stainless
steel MALDI target plate was from Micromass (Milford,
MA, USA).
Preparation of reversed-phase nanocolumns
Reversed-phase nanocolumns were prepared as previously
described.20 Briefly, Porous R2 Resin (¾50 mg) was added to
1-ml isopropyl alcohol to form a slurry. Approximately 2 µl of
the slurry was aspirated into a GELoader tip. The end of the
tip was gently flattened, but not closed, using fine tweezers
that had been preheated over a flame. By pushing liquid
through the flattened tip with a 3-ml disposable syringe, a
packed bed ¾1.5 mm in length was formed near the outlet
of the GELoader tip.
Fabrication of patterned/nonpatterned ODT-coated
plates
MALDI target plates were coated with ODT in complete
coverage or in a pattern. For both procedures, stainless steel
MALDI target plates were first sputter-coated with a 200-
µm-thick gold layer using a Denton Desk II sputter coater
(Denton Vacuum, NJ, USA).
For preparation of a nonpatterned plate, the gold-coated
plate was dipped into 50 mM ODT in ethanol solution for
24 h, then sequentially rinsed with methanol and water, and
air-dried.
Patterned plates consisting of 200-µm gold spots sep-
arated by 4.5 mm on a background of ODT coating were
formed by microcontact printing as outlined in Fig. 1.22 The



















Figure 1. Outline of procedure for preparation of a patterned
ODT plate. Desired pattern is obtained by UV irradiation of
photoresist on Si through a mask (1); PDMS is cast over the
pattern (2) to give a stamp with complementary pattern of relief
(3); the stamp is moistened with ODT (4) and pressed against a
gold plate (5) to form a SAM of ODT on the plate with patterned
200-µm bare gold surfaces (6). Details are given in the text.
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by a high-resolution printer to create a mask. A photoresist-
coated Si wafer was selectively exposed to UV light through
the mask and then immersed in developer to remove
the exposed photoresist. This procedure yielded a mold
consisting of the Si wafer with 200-µm-diameter photore-
sist protrusions in the desired pattern. A PDMS solution
(RTV615A : RTV615B, 5 : 1, v/v) was poured onto the pho-
toresist template and baked for 1–2 h at 80 °C until the
PDMS was cured. The PDMS slice bearing 200-µm-diameter
indentations was peeled off the template and used as a
microcontact-printing stamp. The stamp was immersed into
80 mM ODT ethanol solution for 5 s and then dried with
a stream of N2 gas until only slightly moist. The stamp
was placed onto the gold substrate and pressed gently to
remove air bubbles. After 20 s, the stamp was carefully
removed, leaving an ODT self-assembled monolayer (SAM)
with 200-µm-diameter bare gold spots. Pattern formation
was confirmed by rinsing the plate with water and observ-
ing that water droplets adhered to the plate in the defined
pattern.
Solutions for sample preparation
CHCA was recrystallized in ethanol/water (50 : 50, v/v)
and dissolved in acetonitrile (ACN)/0.1% aqueous TFA
(50 : 50, v/v) to yield a stock solution of 10 mg/ml and
stored at 80 °C. One mg/ml CHCA was used for samples
eluted onto gold plates and 0.5 mg/ml CHCA was used
for samples eluted onto ODT-modified plates. The peptides
were prepared as 1 mg/ml stock solutions in water and
stored at 80 °C until used.
Sample preparation using nanocolumns
Solutions were transferred to the inlet (i.e. the wide end) of
the nanocolumn using a pipette tip. Solutions were forced
through the column using a disposable syringe attached to
the column inlet.20 Prior to loading samples, the column
was wetted with 15 µl of ACN/0.1% TFA (8 : 2, v/v) and
then equilibrated with 10 µl of 0.1% TFA. For analysis of
standards, 5–10-µl peptide solutions diluted in 0.1% TFA
were loaded onto the column and passed through it by
gentle pressure applied using the syringe. Solutions were
eluted from the column by passing 1 µl of CHCA solution
in ACN/0.1% TFA (50 : 50, v/v) slowly through the column
to form a droplet, which was directly deposited onto the
MALDI plate. For brain tissue samples, 10-µl peptide extract
solutions were loaded and the column was then rinsed with
50 µl 0.1% TFA to desalt the samples. CHCA in ACN/0.1%
TFA (75 : 25, v/v) (1 µl) was used to elute the sample.
Sample preparation using C18 Ziptips
A C18 Ziptip (Millipore, Billerica, MA, USA) was initially
wetted by aspirating with ACN/water (50 : 50, v/v) twice,
followed by rinsing with 0.1% TFA solution twice (10 µl each
rinse), as instructed by the manufacturer. Peptide standard
solutions diluted in 0.1% TFA (10 µl) were then aspirated into
the tip and dispensed out 7–10 times to bind the peptides
to the stationary phase in the Ziptip. Peptides were eluted
by aspirating and dispensing 5 µl of ACN/0.1% TFA (50 : 50,
v/v) through several cycles into a sample tube and then
mixed 1 : 1 (v/v) with CHCA solution in ACN/0.1% TFA
(50 : 50, v/v) before deposition onto a MALDI plate. For
brain tissue samples, 10-µl solutions were loaded and the
Ziptip was washed by aspirating and dispensing to waste
10 µl of 0.1% TFA three times before the elution step. For
elution, 1 µl CHCA in ACN/0.1% TFA (75 : 25, v/v) was
used.
Microwave-fixed tissue preparation and
neuropeptide extraction
Male Long Evans rats, 4–8 weeks of age (Charles River
Laboratories, Raleigh, NC, USA) were sacrificed by focused
microwave irradiation (¾3.5 kW applied power for 1.5 s)
using a Muromachi Microwave Fixation System model TMW
(Stoelting Company, Wood Dale, IL, USA). Whole striatum
samples were removed by free-hand dissection and stored at
80 °C until peptide extraction. All animal procedures were
performed under protocols approved by the Institutional
Animal Care and Use Committee of the Centers for Disease
Control and Prevention, National Institute for Occupational
Safety and Health. The animal facility was accredited by
the American Association for Accreditation of Laboratory
Animal Care.
Striatal tissue (50 mg) was placed into 250 µl of cold (4 °C)
homogenization solution containing 145 mM KCl, 8 mM SDS,
and 0.25% acetic acid (v/v). The tissue/homogenization
solution was set on ice for 1 h. Throughout the 1-h period,
tissue homogenization and cell lysis were aided every
10 min by 5-s sonication using a sonic dismembrator (Fisher
Scientific, Chicago, IL, USA) on power-setting 3 followed
by 30 s of vortexing. The homogenate was centrifuged at
20 000 ð g for 30 min at 4 °C. The supernatant containing
both proteins and neuropeptides was removed from the
resulting tissue pellet and filtered using a Microcon YM-10
centrifugal filter (Millipore, Billerica, MA, USA) fitted with a
30-kDa membrane to separate proteins from peptides.1 The
filter device was then placed into a centrifuge and spun at
14 000 ð g for 45 min. The peptide-rich filtrate was frozen by
liquid N2 and stored at 80 °C until analysis. A portion of
the homogenization solution without the added tissue was
retained and used as control sample for spotting onto the
MALDI plate.
Mass spectrometry
Mass spectra were acquired with a MALDI TOF Spec 2E mass
spectrometer (Micromass, Milford, MA, USA) equipped
with a delayed extraction source and 337-nm pulsed (4 ns)
nitrogen laser operated in the reflectron mode. All mass
spectra were obtained in positive ion mode with 20 kV
source voltage, 2.2 kV extraction pulse voltage, 19.98 kV
extraction voltage, 16 kV focus voltage, and suppression
mass of 500 m/z with scan extended to 5000 m/z. The size
of the laser spot was 150 ð 250 µm. Mass spectral data were
generated by summing 10 to 50 scans (each scan corresponds
to five laser shots) into a single spectrum. External calibration
was performed on all spectra.
Scanning electron microscopy
A Hitachi S3200N scanning electron microscope (SEM)
(Hitachi Ltd., Tokyo, Japan) operated in high-vacuum mode
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with 3.5-nm resolution using a secondary electron scintillator
detector was used to collect images of MALDI sample spots.
SEM images were obtained using medium beam current and
20 kV accelerating voltage with 2000ð magnification.
RESULTS AND DISCUSSION
Patterned versus nonpatterned ODT plates
Initial experiments were performed to evaluate the use of
patterned surfaces as sample supports. Because the spot
size of the lasers commonly used in MALDI instruments
is between 50 and 200 µm, it is useful to generate small
sample spots that are roughly equivalent to the size of
the laser spot so that most of the analyte molecules can
be ionized upon laser irradiation.20,23 The patterned ODT
plates made by the microcontact printing method have bare
gold spots surrounded by a hydrophobic thiol layer similar
to prestructured supports12,24 – 26 that should allow sample
confinement to the size of the well. The ability of these
structures to control sample spot size was confirmed by
observing that crystals formed from deposition of a 1-µl
droplet of 2.5 mg/ml aqueous CHCA solution onto a plate
were confined to a 200-µm-diameter circle matching the size
of the gold spots (Fig. 2(A) and (B)). These spot sizes are 1/10
times the diameter of those obtained for the same volume by
dried-droplet method. As summarized in Fig. 3, the smaller
sample spots obtained from aqueous samples deposited onto
a patterned ODT plate generated about 10 to 50 times higher
signal for four peptide standards than the same samples
deposited onto a gold plate. To avoid bias in this comparison,
when acquiring data from dried-droplet samples, the laser
in the mass spectrometer was scanned manually to search
for ‘hot spots’; while for samples deposited on ODT plate,
laser spot irradiated upon the center of the spots where the
samples were deposited.
We then investigated the use of nonpatterned surfaces
coated with ODT. Because of the hydrophobicity of the
ODT-modified surface, aqueous sample spots deposited
onto a nonpatterned ODT plate were confined to spot size
nearly identical to that of the patterned surface (Fig. 2(C)).
The sample manually deposited on nonpatterned ODT
was not always in the center of the spot; therefore when
acquiring data by MALDI-TOF MS, the laser was moved
to irradiate right on top of the sample spot. The resulting
signal intensities for peptide standards in aqueous solutions
were similar to those samples deposited onto the patterned
surface, although some variation was seen with different
peptides (Fig. 3). Except for vasopressin (VP), the signal
intensities obtained from nonpatterned ODT plate were not
significantly lower than those obtained from patterned ODT
plate (p < 0.05), and were even higher for neurotensin
1–11. (All statistical comparisons were performed using a
one-tailed t-test.) Both patterned and nonpatterned ODT
plates generated significantly improved signal intensities
over bare gold plates (p < 0.05), presumably due to the
concentration effect of confining the samples to smaller spots.
The patterned surface did not appear to offer significant
advantages relative to the simpler-to-prepare nonpatterned
plate; therefore, further experiments utilized nonpatterned
ODT-coated plates.














Patterned ODT plate, sample in water
Nonpatterned ODT plate, sample in water
Nonpatterned ODT plate, sample in 50% ACN
Gold plate, sample in water
Figure 3. Comparison of the intensity of mass spectral signal
generated for deposition of 1 µl of neuropeptide mixture onto a
patterned ODT-coated plate, a nonpatterned ODT-coated
plate, and a gold plate with dried-droplet method. Four
neuropeptides were in the mixture: 20 nM vasopressin (VP),
20 nM bradykinin(BK), 20 nM angiotensin II (AG II), and 50 nM
neurotensin 1–11 (NT 1–11). All results are the average with
error bar equal to 1 standard deviation (n D 6). * indicates
significantly lower S/N than the rest of the methods for each
individual peptide.
(A) (B) (C)
Figure 2. SEM image of patterned ODT plate with 200-µm hydrophilic spot (A); crystals formed from deposition of 1 µl of 2.5 mg/ml
CHCA solution deposited on a hydrophilic spot of the patterned ODT-modified plate (B); and crystals formed from deposition of 1 µl
of 2.5 mg/ml CHCA solution deposited onto nonpatterned ODT plate (C). Scale bar corresponds to 100 µm.
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Further experimentation with ODT-coated plates reve-
aled that as the percentage of ACN in the sample increased,
the resulting sample spot size also increased. Using a
solvent containing 50% ACN, the spot size of 1-µl sample
solution on a nonpatterned ODT-coated plate was as large
as 1 mm in diameter. (This effect was also found with
the ODT-plate patterned with hydrophilic spots similar to
that reported previously.13) Because we anticipated using
the plates to capture samples eluted from a solid-phase
extraction cartridge with high organic solvent content, this
effect was limiting. Using DHB as matrix allowed samples
to be confined to small spots with up to 75% ACN as
solvent; however, DHB as matrix generated much lower
signal intensities than CHCA as matrix for the neuropeptides
we tested.
To diminish sample spreading when using high organic
solvent content, samples were deposited in multiple steps.
In this approach, a fraction of effluent was deposited
and allowed to evaporate before the next fraction was
added. Using 2–3 deposition steps for an eluent volume
of 1 µl, spot sizes of ¾500 µm could be obtained on the
ODT plate with 50% ACN in the sample. When the same
deposition procedure was used on an unmodified gold
plate, the sample spot could not be confined to such
small size and the resulting signal intensity was lower.
For example, the signal for neurotensin 1–11 in 50% ACN
on the ODT plate was ¾12 times higher as compared to
that obtained with the gold plate. As shown in Fig. 3, using
this multistep deposition method for peptide standards (in
50% ACN) deposited on a nonpatterned ODT plate resulted
in signals not significantly different from those achieved
for aqueous solutions deposited on the same plate (except
for AG II), despite slightly larger sample spots (500 µm
compared to 200 µm for the aqueous samples). It is possible
that differences in crystallization rate allowed the signal
to be maintained despite the larger, and presumably less
concentrated, spot. Water is less volatile than ACN; therefore,
CHCA crystallizes more slowly in aqueous solution. Slower
crystallization usually results in more crystal aggregation
within sample spots, thus affecting the signal intensities.27
From these results, we conclude that ODT-coated plates can
be used to obtain good sensitivity for samples with relatively
high organic solvent content as long as multistep deposition
is used.
The effect of matrix concentration on sensitivity was
tested for neurotensin 1–11 samples deposited on ODT-
coated and unmodified gold plates. We found that 0.5 mg/ml
CHCA and 1 mg/ml CHCA gave the best sensitivities for
neurotensin 1–11 deposited on ODT plate and on gold plate,
respectively (data not shown). These concentrations were
used for all further experiments.
Improved LOD combining nanocolumn with ODT
plates
We evaluated if the ODT-coated plates would be of benefit
for improving sensitivity when combined with solid-phase
extraction methods by determining the LODs for vasopressin
and neurotensin 1–11 using the dried-droplet, Ziptip, and
nanocolumn methods (see ‘Experimental’ section for details
on use of these methods) with samples deposited onto a bare
gold plate or an ODT-coated plate. LODs were determined
by calculating the concentration that would give a signal-
to-noise ratio (S/N) of 3 assuming a linear relationship
between S/N and concentration. To minimize error from
this assumption, the concentration of sample used in different
deposition methods was adjusted to obtain S/Ns in the range
of 3–10. Noise was measured as the average peak-to-peak
noise at 50 m/z adjacent to the peak. LODs were calculated
on the basis of the initial sample volume, i.e. 1 µl for dried-
droplet, 10 µl for Ziptip, and 5 µl for nanocolumn sample
preparation. Using these criteria, we found that the ODT-
coated plates significantly improved (p < 0.05) the LOD
6- to 60-fold over gold plates for each individual deposition
method and peptide (Table 1), which reaffirmed experiments
summarized in Fig. 3. The performance of the ODT-coated
plates is comparable to other modified or prestructured
surfaces when used with similar deposition methods.12
These results also allow an evaluation of the effectiveness
of the use of nanocolumns for sample extraction and
deposition. A direct comparison among the deposition
methods is not valid because different starting volumes
were used; however, the sample volumes used represent
the maximum that is conveniently used with each method
and therefore provide a comparison under best case for
all methods. As expected, the methods using solid-phase
extraction were significantly improved over the dried-
droplet method (Table 1). The nanocolumns and Ziptip
extractions provided similar mass LODs of ¾100 amol
on the ODT-coated plates; however, the nanocolumns
provide statistically significant (p < 0.05) improvements in
concentration LOD of about five-fold over the Ziptip method.
Detection of peptides at low picomolar concentration
by this method is illustrated by the MALDI-TOF mass
spectrum obtained from 5 µl of a mixture of vasopressin
Table 1. LOD for neurotensin 1–11 (NT 1–11) and vasopressin (VP) deposited via various methods on different plates
Gold plate ODT-coated plate
Peptide LOD DD Ziptip Nanocolumn DD Ziptip Nanocolumn
NT 1–11 mLOD (amol) 6000 š 4000 4000 š 2000 3000 š 1000 500 š 300 100 š 70 100 š 50
cLOD (nM) 6 š 4 4 š 2 0.6 š 0.2 0.5 š 0.3 0.1 š 0.07 0.02 š 0.01
VP mLOD (amol) 3000 š 1000 800 š 500 1000 š 500 400 š 200 100 š 30 80 š 4
cLOD (nM) 3 š 1 0.8 š 0.5 0.2 š 0.1 0.4 š 0.2 0.1 š 0.03 0.02 š 0.001
DD indicates dried-droplet deposition; mLOD and cLOD indicate mass LOD and concentration LOD respectively. All LODs are the
average from 6 repetitions calculated as described in the text.
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Figure 4. MALDI-TOF mass spectrum of vasopressin and
neurotensin 1–11 mixture (20 pM, 100 amol each), prepared
with nanocolumn/ODT-plate method. The spectrum is a sum of
10 scans.
and neurotensin 1–11 at 20 pM each in Fig. 4. The low
picomolar concentration LOD of the nanocolumn/ODT-
plate method is better than other deposition methods
utilizing specialized surfaces that achieved sub-nanomolars
to 10 nM concentration LOD.11 – 14
The much-improved concentration LOD by the nanocol-
umn over the Ziptip (Table 1) is largely due to the ability
to use a low elution volume (1 µl) which can be entirely
deposited into a single small spot. In contrast, the Ziptip
required a larger volume to elute all sample (5 µl), prevent-
ing deposition into a single, small spot. This difference is
due to the lower volume of the packed bed in the nanocol-
umn (30–50 nl)20 compared with the Ziptip (600 µl). Another
reason for improved LOD with the nanocolumn is that the
narrow outlet of the GELoader tips, combined with mul-
tistep deposition, allows formation of small sample spots
(200–300 µm), so that most of the sample can undergo ion-
ization upon laser irradiation. As a result of this combination
of factors, the nanocolumn is more useful for achieving
low concentration LOD with limited sample volumes. This
advantage is significantly heightened by using an ODT-
coated plate. The trace level detection capability combined
with sample purification suggested that the method could be
used for determination of neuropeptides in complex media,
such as brain tissue extracts.
Brain tissue study
‘Neuropeptidomics’, wherein many peptides are detected
or identified in nervous tissue samples, is rapidly becom-
ing a valuable tool for neurochemistry. Methods utilized
for such analyses include capillary liquid chromatography-
electrospray ionization mass spectrometry (cLC-ESI-MS),1,28
direct MALDI-MS analysis of tissue8,29 and LC-MALDI-
MS.6,30,31 Such methods have been valuable for identi-
fying novel neurotransmitter candidates, determining the
distribution of neuropeptides, and studying peptide process-
ing. In view of the good sensitivity of the nanocolumn/ODT-
plate method, we evaluated its use for neuropeptidomic
analysis of mammalian brain tissue.
Tissue extracts from striatum of rats sacrificed by
microwave irradiation were used for this study. Microwave
irradiation has been shown to fix tissue32 and cause heat-
induced denaturing of peptidase activity, resulting in an
improved yield of neuropeptides over other methods of
sacrifice.33 Figure 5 compares spectra obtained with the
nanocolumn/ODT-plate method, wherein 30 peaks were
detected, with those obtained with the Ziptip/gold-plate
method, wherein only 4 peaks were detected. These results
illustrate that the combination of miniaturized columns,
controlled deposition, and ODT-coated plates gives a
significantly higher coverage of the neuropeptidome than
the more conventional approach.
In analysis of extracts from two brains, we detected a
total of 98 peaks that were not found in spectra obtained
from the control homogenization solution. Without MS/MS
capability, we had insufficient information to confidently
identify the peptides from the masses detected. Pilot
experiments using postsource decay on the MALDI-TOF
MS instrument failed to generate reliable spectra, possibly
because of the low levels. In a parallel study in our
laboratory, the same samples were also analyzed using
1000 2000 3000 4000 5000
1000 2000 3000 4000 5000
m/z

















Figure 5. MALDI-TOF mass spectra of extract from
microwave-fixed brain tissue samples prepared by
Ziptip/gold-plate method (A) and nanocolumn/ODT-plate
method (B). An insert of spectrum (B) is shown in spectrum (C).
Labeled peptides correspond to: 1. thymosin beta-10;
2. thymosin beta-4; 3. YGGFMRF; 4. YGGFMRGL;
5. TEEELSPTEEE; 6. substance P;
7. RPKPQQFFGLM(O)-amidation; 8. neuropeptide E-I;
9. VGRPEWWMDYQ-amidation; 10. rimorphin;
11. acetyl-SGSAKVAFSAIRSTNH; 12. CLIP. Each spectrum is
a sum of 50 scans. M(O) indicates methionine sulfoxide.
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(calculated) Sequence Peptide Precursor/protein Sources
877.42 877.40 YGGFMRF Met-enkenphalin RF Proenkephalin A precursor 1,3
900.48 900.44 YGGFMRGL Met-enkenphalinRGL Proenkephalin A precursor 1,3
1149.65 1149.60 VAYWRQAGLS – Neurogranin 3
1165.77 1165.73 TEEELSPTEE – Protein-tyrosine
phosphatase 1B
2




1347.78 1347.74 RPKPQQFFGLM-amide Substance P Protachykinin 1 1
1363.70 1363.73 RPKPQQFFGLM(O)-amide Substance P Protachykinin 1 2
1385.70 1385.69 SPQLEDEAKELQ – Proenkephalin A 3
1447.78 1447.71 EIGDEENSAKFPI-amide Neuropeptide E-I Pro-MCH precursor 1
1466.69 1466.65 VGRPEWWMDYQ – Proenkephalin A 1,3
1483.84 1483.85 FAVLKLM(O)GRGTKF – Myelin proteolipid protein 2
1505.70 1505.71 EIGDEENSAKFPIG – Pro-MCH precursor 1




1637.93 1637.96 AKVAVLGASGGIGQPLSL – Malate dehydrogenase,
mitochondrial precursor
3
1675.80 1675.86 Acetyl-SGSAKVAFSAIRSTNH – Cerebellin 3
1744.76 1744.82 EAEERGDLGEGGAWRL – Thyroliberin 3
1817.90 1817.82 QDNEPEKPVADSETKM – Excitatory amino acid
transporter 2
3
1847.87 1847.95 PSSISWDGLDPGKLYTL-amide – Phosphatidylethanolamine
binding protein
1,3
2132.02 2132.12 LVQTQAATTDSDKVDLSIAR – Fibrinogen beta chain
precursor
3
2506.11 2506.26 RPVKVYPNVAENESAEAFPLEF CLIP Pro-opiomelanocortin 1
2617.18 2617.20 EEEEKDIEAEERGDLGEGGAWRL – Thyroliberin 3
4934.7 4934.53 Acetyl-
ADKPDMGEIASFDKAKLKKT
Thymosin beta-10 Thymosin beta-10 1
ETQEKNTLPTKETIEQEKRSEIS
4961.7 4961.49 Acetyl-SDKPDMAEIEKFDKSKLKKT Thymosin beta-4 Thymosin beta-4 1
ETQEKNPLPSKETIEQEKQAGES short form
1. Andren et al. J. Proteom. Res. 2003; 2: 213–270.
2. Minamino et al. J. Chromatogr. B 2003; 792: 33–48.
3. Parkin et al. Anal. Chem. 2005; 77: in press.
Mass indicates [M C H]C. M(O) indicates methionine sulfoxide.
capillary liquid chromatography-electrospray ionization-
quadrupole ion trap mass spectrometry (cLC-ESI-QIT-
MS) operated in the data-dependent mode. This method
applied to similar tissue allowed acquisition of MS/MS
spectra and peptide identification using the database-
searching algorithms SEQUEST and Mascot (data not
shown), yielding 95 identified peptides. Furthermore, similar
samples have been previously analyzed by cLC-ESI-QTOF-
MS with 89 peptides identified.1,2 Comparison of the 98
compounds detected in our samples with those detected
in the previous studies revealed that 23 peptides had
masses that were within the accuracy of the instrument
(difference between calculated and measured monoisotopic
mass  50 ppm) as summarized in Table 2. These peptides
include several known neuropeptides or related compounds
such as substance P, neuropeptide E-I, and corticotrophinlike
intermediate lobe peptide (CLIP).
While these assignments should be considered tentative,
the results strongly suggest that the MALDI-TOF method
combined with the nanocolumn/ODT plate can be used to
detect endogenous neuropeptides in tissue samples. Use of
tandem mass spectrometry is expected to allow identification
from MALDI-TOF MS data. More selective sample prepara-
tion procedures, such as affinity purification34 or chromatog-
raphy separation,15,35 may be used to target specific peptides
for analysis. The combination with chromatographic separa-
tion may decrease competitive ionization and improve the
yield of peptides detected.
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CONCLUSION
We have demonstrated that combination of a nanocolumn
with hydrophobic ODT-coated sample plates allows sen-
sitive detection of neuropeptides in complex samples by
MALDI-MS. While nanocolumns and hydrophobic or pre-
structured supports have both been previously used, the
combination of these methods is revealed to offer significant
sensitivity improvements, especially in concentration LOD
of real samples, over either method independently. The sen-
sitivity of the method, which allowed concentration LOD as
low as 15 pM, is attributed to combining preconcentration
and desalting with plate modifications to decrease the size
of the resulting sample spot. The method is simple to imple-
ment on any TOF-MS and applicable to complex analyses
where the sample is limited. The simplicity and sensitivity of
the method should make it useful for numerous applications.
The demonstration of neuropeptide detection in select brain
regions in this work is an example of a demanding appli-
cation made possible by this sample preparation method.
Combination with tandem mass spectrometry the method
may enable this method to be used for confident peptide
identification as well.
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